12 Recruiting Acute Myeloid Leukemia Clinical Trials in Massachusetts
Explore active acute myeloid leukemia research studies enrolling across Massachusetts. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Acute Myeloid Leukemia Studies in Massachusetts
A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Ruxolitinib + Allogeneic Stem Cell Transplantation in AML
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
📍 Boston Children's Hospital — Boston, Massachusetts
View Study & Checklist ➔Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔CIML NK Cells With Venetoclax for AML
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Ziftomenib Maintenance Post Allo-HCT
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
📍 Boston Children's Hospital — Boston, Massachusetts
View Study & Checklist ➔BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔